Glaxo Vaccine Works on Cervical-Cancer Virus in Study
307115
GlaxoSmithKline Plc&#39;s experimental vaccine was effective against a virus that causes cervical cancer in a study, the first to show the treatment may provide protection against the No.
551343
Years of clinical trials have yielded promising results for a vaccine that would protect women from a virus that causes cervical cancer.
358227
A cancer vaccine for non-small-cell lung cancer (the most common type) appears to be effective for patients whose cancer has not spread to other parts of the body
47841
NEW YORK NOV 11, 2004  - In a study conducted in North America and Brazil, a bivalent vaccine was effective in preventing infection with the two most common oncogenic human papillomavirus (HPV) types -- HPV-16 and HPV-18.
581139
All girls of 11 in the EU should be vaccinated against the virus that causes cervical cancer, a medical journal says.
393599
Treating patients who have glioblastoma multiforme, a lethal type of brain tumor, with an experimental vaccine seems to sensitize the tumor to subsequent chemotherapy, according to a study by researchers at Cedars-Sinai Medical Center in Los Angeles.
440893
A new vaccine could prevent the majority of cases of cervical cancer, suggest the results of a major trial. The vaccine protects against the virus that causes cervical cancer, which kills almost a quarter of a million women worldwide each year.
473096
Doctors hope the new vaccine against human papillomavirus will be able to prevent a less well-known disease in gay men, anal cancer.
131627
Researchers believe an experimental vaccine could possibly offer protection against the virus that causes most cervical cancer. A three-year study of 2,400 women found only seven vaccinated women developed
42857
The vaccine targets the two most common types of cervical cancer-causing human papillomavirus (HPV), HPV-16 and HPV-18. In a randomized, controlled trial, US researcher Diane Harper from Dartmouth Medical
6247
Years of clinical trials have yielded promising results for a vaccine that would protect women from a virus that causes colon and cervical cancer, researchers said on Monday.
419424
It's one of the most common cancers in women and kills about a quarter of a million patients each year but scientists said on Friday that a new vaccine could prevent most cases of cervical cancer.
55559
A gel to destroy cervical cancer cells and minimise the threat of disease is under development.
704782
By The Columbus Dispatch, Ohio  Feb. 5--Merck & Co. has plenty of reasons to want its new cervical-cancer vaccine to be mandatory for girls. Potentially billions of reasons.   The vaccine, Gardasil, has been judged safe.
9849
Almost 250,000 women worldwide die each year from cervical cancer, which is linked to infection by HPV viruses. Experts believe that vaccination against the most common cancer-causing viruses, HPV-16 and HPV-18, could prevent up to 70% of cases.
674760
By Leigh Woosley, Tulsa World, Okla.  Feb. 19--Mary Bryce Fox didn't ask her daughters. She told them.   The girls would get a controversial vaccine that protects against the sexually transmitted disease that causes genital warts and most cervical cancer.
509725
A Merck vaccine, which makes people immune to a common sexually transmitted virus (human papilloma virus - HPV) which causes cervical cancer, seems to continue offering protection from cervical cancer two years after preliminary testing, say scientists at